Your new post is loading...
Researchers at Imperial College London recently went to great lengths to obtain psilocybin and use it in clinical tests to investigate its medicinal value for treating severe depression.
It took 32 months for the research team to meet all the licensing requirements to even conduct the trial. They also commented that the price per dose was literally 50 times more than what it should have cost in a "sane world."
Twelve participants with severe depression signed up to receive high doses of the banned psilocybin. They were given capsules orally and monitored closely.
The medicinal properties of psilocybin were quickly realized. In just one week, all the participants were free of depression and self loathing. After three months, there were no lingering symptoms of depression whatsoever for five of the participants.
Now that would put a kink in the pharmaceutical business plan...